Two Sigma Securities’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
SIAU
QF
RCMNY
PSC
Two Sigma Securities's ROIV Position: Q3 2025 in Review
Two Sigma Securities sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 18,769 shares — an estimated $212K sold.
Two Sigma Securities first reported a position in ROIV in Q3 2023 and held it in 3 quarters. The position peaked at $212K in Q2 2025. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.
- Two Sigma Securities reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
- Two Sigma Securities sold 18,769 Roivant Sciences shares in Q3 2025, an estimated $212K.
- Two Sigma Securities first reported a position in Roivant Sciences in Q3 2023 and held it in 3 quarters.
- Two Sigma Securities's Roivant Sciences position peaked at $212K in Q2 2025.
- 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.
Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.